Literature DB >> 2458194

Identification of the collagen-binding domain of vitronectin using monoclonal antibodies.

M Izumi1, T Shimo-Oka, N Morishita, I Ii, M Hayashi.   

Abstract

Vitronectin is a 75 kilodalton (kDa) cell-adhesive glycoprotein found in animal blood and connective tissue, also termed serum spreading factor, S-protein, and epibolin. It promotes attachment and spreading of animal cells on tissue culture dishes, and it also binds to collagen. We established four mouse hybridoma lines producing monoclonal antibodies (M1, M2, M4 and M5) to human vitronectin. By immunoblotting, both epitopes recognized by M4 and M5 were suggested to exist in the amino terminal 5 kDa portion of vitronectin, and both M1 and M2 bound to the adjacent 35 kDa portion. Cell spreading on vitronectin-coated dishes was inhibited by M4 = M5 greater than M1, but not by M2. Collagen binding to vitronectin was inhibited by M2 greater than M4 = M5, but not by M1. These results indicate that the collagen-binding site is located near the cell-binding site in the amino terminal half of vitronectin. Independent inhibition of vitronectin binding to the cell and to collagen by these monoclonal antibodies will provide a potential tool to dissect the structure and function of vitronectin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458194     DOI: 10.1247/csf.13.217

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  11 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Activation of blood coagulation and fibrinolysis in vibration syndrome.

Authors:  R Shunto; A Shirakami; A Ohara; N Toibana; S Saito
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

3.  A pre-clinical functional assessment of an acellular scaffold intended for the treatment of hard-to-heal wounds.

Authors:  Gary K Shooter; Derek R Van Lonkhuyzen; Tristan I Croll; Yang Cao; Yan Xie; James A Broadbent; Dario Stupar; Emily C Lynam; Zee Upton
Journal:  Int Wound J       Date:  2013-04-05       Impact factor: 3.315

4.  Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.

Authors:  Yan Ji; Tammy L Strawn; Elizabeth A Grunz; Meredith J Stevenson; Alexander W Lohman; Daniel A Lawrence; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-12       Impact factor: 8.311

Review 5.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

6.  Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.

Authors:  N Garg; N Goyal; T L Strawn; J Wu; K M Mann; D A Lawrence; W P Fay
Journal:  J Thromb Haemost       Date:  2010-05-12       Impact factor: 5.824

7.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Complement inhibition by human vitronectin involves non-heparin binding domains.

Authors:  M Sheehan; C A Morris; B A Pussell; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge.

Authors:  T D Duensing; J P Putten
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

10.  A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.

Authors:  Christine R Schar; Grant E Blouse; Kenneth H Minor; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.